Liver Disease Drugs Research

2 comprehensive market analysis studies and research reports on the Liver Disease Drugs sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 34 companies, enriched with industry statistics, insights, and a lot more.

Liver Disease Drugs Industry Mordor Intelligence
Dots and Lines - Pattern
2 Healthcare Reports
Categoriesdown
Filters and Sort
Liver Diseases Therapeutics Market Major Players
Liver Diseases Therapeutics Market
CAGR: 7.63%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Abbott Laboratories, Novartis, Gilead Sciences, Sanofi, Astellas Pharma
Primary Biliary Cholangitis (PBC) Therapeutics Market Major Players
Primary Biliary Cholangitis (PBC) Therapeutics Market
CAGR: 8.42%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Abbvie, Glenmark Pharmaceuticals, Intercept Pharmaceuticals, Teva Pharmaceutical Industries, Viatris (Mylan)
Yay! You have seen it all
Dots and Lines - Pattern
CONTACT US

When decisions matter, industry leaders turn to our analysts. Let’s talk.

🌐Country code
down